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Abstract: Over the last decades, much effort has been devoted to the 
design of the “ideal” library for screening, the most promising 
strategies being those which draw inspiration from biogenic 
compounds, as they seek to add biological relevance to such libraries. 
On the other hand, there is a growing understanding of the role that 
molecular complexity plays in the discovery of new bioactive small 
molecules. Nevertheless, the introduction of molecular complexity 
must be balanced with synthetic accessibility. In this work, we show 
that both concepts can be efficiently merged -in a minimalist way- by 
using very simple guidelines during the design process along with the 
application of multicomponent reactions as key steps in the synthetic 
process. Natural phenanthrenoids, a class of plant aromatic 
metabolites, served as inspiration for the synthesis of a library where 
complexity-enhancing features were introduced in few steps using 
multicomponent reactions. These resulting chemical entities were not 
only more complex than the parent natural products, but also 
interrogated an alternative region of the chemical space, which led to 
an outstanding hit rate in an antiproliferative assay: four out of twenty-
six compounds showed in vitro activity, one of them being more potent 
than the clinically useful drug 5-fluorouracil. 
Introduction 
Despite the advances on the synthesis of large compound 
libraries and on high-throughput screening technologies, the 
discovery of new biological active molecules that might help in 
fighting against deadly diseases remains a slow and somehow 
unpromising task, mainly because the structural factors 
necessary to create compound collections with a potent and 
specific biochemical activity are not fully understood.[1] Moreover, 
there is an increasing awareness that most drugs not only act on 
a single, but on multiple targets,[2] and perhaps the extensive use 
during the past decades of target-based approaches for finding 
active chemotypes may account for the decrease in the pace 
of discovery of new drugs.[3–5] 
In recent years, a trend has emerged towards addressing this 
issue, based on the design of libraries that take inspiration 
from natural products (NPs). Some of these approaches 
employ a strategy that incorporates scaffold usually present 
on NPs into the design process, the widely known Biology 
Oriented Synthesis (BIOS), introduced by Waldmann, being 
one of the most promising.[6,7] The rationale behind BIOS is 
that natural product fragments have a higher probability of 
binding to protein domains, and as proteins are built up 
modularly from a limited number of domain types, similar 
small molecules should be expected to bind to evolutionarily 
rather than functionally related proteins. Thus, focused 
libraries are designed around core scaffolds delineated from 
NPs in order to generate diversity from biologically pre-
validated starting points.[8] The most crucial step in this 
process is identifying the relevant fragments that might 
confer biological relevance to the compounds to be 
synthesised. Only recently chemoinformatic tools have been 
developed for mining the information contained in the rapidly 
growing chemical databases, which have shed some light on 
this problem. Using such tools, Waldmann proposes a 
classification of the most biologically relevant scaffolds found 
in NPs, which might serve as a guideline for the selection of 
fragments on which to base the synthesis of rather small 
chemical libraries of less than 500 members, where a hit rate 
in biological screenings as high as 1.5% can be achieved.[7,9]   
As a consequence, the chemical modification of isolated 
NPs, which are inherently complex molecules, using 
synthetic procedures suitable to further increase the 
complexity, is a logical approach for generating small 
synthetic molecules that, although would be not direct 
analogs of a particular NP, could be considered as mimics 
enriched in the structural features of NPs, thus rising the 
chance of discovering new biologically relevant chemotypes. 
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Another important conclusion derived from chemoinformatic 
analysis of vast collections of compounds is that the 
complexity of a molecule has a paramount role in drug 
discovery.[10,11] Although there is no universally accepted 
definition, the concept of molecular complexity seems quite 
intuitive, and some simple and easily interpretable measures 
to assess it have been proposed during the last decade. For 
example, Lovering et al. [12] introduced the Fsp3 metric 
(number of sp3 hybridised carbons/total carbon count). In 
turn, Clemons et al. defined stereochemical complexity as 
the proportion of stereogenic carbon atoms in a molecule, 
and demonstrated that these descriptors highly correlate with 
the frequency and binding selectivity of a given compound to 
biological targets,[13] probably because the presence of non-
flat molecular frameworks capable of orienting peripheral 
functional groups in all three dimensions might add the 
complementarity needed for binding to protein surfaces.[14] 
Only recently these appealing ideas have been implemented 
for the synthesis of Fsp3-rich libraries.[15–17] 
In the same vein, an extensive statistical analysis reported 
by Feher and Schmidt[18] suggests that some simple 
principles should be considered when designing new 
chemotypes for screening. In other words, increasing the 
number of chiral centres, fused rings, nitrogen and oxygen 
atoms while keeping the ratio between aromatic and 
saturated rings low may render a more biologically relevant 
compound. Taken together, these studies suggest that the 
aforementioned principles might serve as an intuitive 
guideline when designing such new chemical entities. But, 
as stated by Feher and Schmidt, introducing the required 
complexity-enhancing features into a molecule may imply 
substantial synthetic costs, such as the need for multiple 
cyclisation reactions and the formation of a number of 
carbon-carbon bonds.[18] This is the case of the work 
performed by Paciaroni et al., who described the synthesis 
of a 70-member library of compounds inspired on the 
alkaloidal scaffold of yohimbine, from which some bioactive 
compounds were discovered.[19] The ring distortion strategy 
reported by these researchers is a good example of the 
sophisticated but rather complex chemistry needed to 
achieve this goal. As an alternative, multicomponent 
reactions (MCRs) are powerful, highly convergent synthetic 
procedures that might help to overcome the synthetic costs 
associated to the efficient introduction of complexity-
enhancing features. Most of these reactions are 
operationally simple and are especially useful for generating, 
in few steps, scaffolds with a structure closely resembling 
that of NPs. The Ugi four-component reaction (U-4CR), 
which is based on the exceptional reactivity of the isocyanide 
functional group, is probably the most powerful MCR and 
occurs when a carbonyl compound, an amine, a carboxylic 
acid and an isocyanide react together to give an α-
aminoacylamide.[20] As a consequence, at least two oxygen 
and two nitrogen atoms, along with two sp3 centres, can be 
introduced in one step, with the concomitant formation of 
three new bonds, all this without considering the variety of 
scaffolds that can be introduced through the appropriate 
choice of the components participating in the reaction. 
In this context, the aim of this work is to explore whether a 
library whose design relies on the combination of the BIOS 
philosophy to choose a relevant scaffold and further 
complexity enhancement using the principles suggested by 
recent chemoinformatic studies, while still maintaining the 
synthetic chemistry involved as easy as possible, will indeed 
lead to a set of relevant chemotypes with a higher hit rate of 
bioactive compounds.   
Results and Discussion 
A library of phenanthrenoid mimics was outlined using 
simple design principles 
The first step in the design of the library is the proper choice 
of a scaffold as a core for generating more complex 
chemotypes, bearing some constraints in mind: it should be 
one of the fragments proposed by the BIOS approach and it 
should have, at the same time, a low structural complexity as 
measured by the Fsp3 metrics. Therefore, we conducted a 
thorough search in the literature, from which the relatively 
unexplored phenanthrene ring system emerged as a suitable 
scaffold. Natural phenanthrenes, collectively known as 
phenanthrenoids, are a class of aromatic metabolites 
belonging to the broader family of stilbenoids.[21] 
Phenanthrenoids act as phytoalexins during the plant 
response to pathogens, and have been demonstrated to 
possess various types of biological activity, such as cytotoxic, 
anti-inflammatory and antimicrobial, that have been reviewed 
recently.[22] For example, denbinobin, isolated from 
Dendrobium moniliforme, prevents the binding of the 
transcription factor NF-κB to DNA, inducing apoptosis in 
human leukemic cells,[23] whereas the 9,10-dihydro-2,5-
dimethoxyphenanthrene RSCL-0520, isolated from Eulophia 
ochreata, inhibits the inflammatory signalling mediated by 
toll-like receptor TLR4 in RAW264.7 macrophages [24] 
(Figure 1). 
 
To better characterise the complexity of this family of natural 
compounds, we mined the literature[22,25] and selected 72 
natural phenanthrenoids ‒whose structures are collected in 
the Supporting Information file‒ as a representative sample. 
We calculated their Fsp3 scores and found a mean value of 
0.22 (median=0.20). This value is significantly lower than that 
typically reported for NPs, which range from 0.41 to 0.59, 
depending on the set of compounds analysed.[1,26] 
Interestingly, all natural phenanthrenoids contain oxygen 
atoms, but none has nitrogen or other heteroatoms, which 
are known to contribute to the biological relevance of a given 
chemotype, in their structures. 
Figure 1. Examples of biologically active natural phenanthrenoids. 
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Scheme 1. U-4CR on phenanthrene 1.  
Reagents and conditions: a. R1-NH2 / R2-NC / HCHO / methanol or 
ethanol; r.t; 48h 
The next step comprised the selection of an appropriate 
synthetic strategy to generate the desired library. With this 
purpose, we chose the 9,10-dihydrophenanthrene 1, which 
can be easily obtained from the readily available steroid 
estrone [27] as the carboxylic component for an U-4CR, and 
selected some amines and isocyanides containing both 
aliphatic and aromatic moieties and N, O or P-based 
functional groups (depicted in Table 1), pursuing, at the same 
time, the introduction of additional scaffolds suggested by the 
BIOS strategy into the final compounds. From these 
components, we straightforwardly obtained the first 
members of the library, compounds 2a – l (Scheme 1). 
 
Table 1. Amines and isocyanides used in the U-4CR depicted in Scheme 1. 
 
Compound R1-NH2 R2-NC 
2a 
 
 
2b 
 
 
2c 
  
2d 
 
 
2e 
  
2f 
  
2g 
 
 
2h 
  
2i 
  
2j 
  
2k 
  
2l 
 
 
 
One of the most remarkable features of MCRs is that they 
offer additional opportunities for post-condensation 
modifications of the reaction products,[28] which in this 
context might help to expand the complexity of the final 
chemotypes. Thus, we designed a series of compounds 
were, by using 2,2-diethoxyethanamine and suitable 
isocyanides in the U-4CR, intermediates 2h – l were obtained, 
which were then subjected to subsequent treatment under acidic 
conditions, to give the corresponding cyclisation products 3a and 
3b. In addition, intermediates derived from electron-rich aromatic 
isocyanides suffered an additional Pictet-Spengler type reaction 
[29] to give the complex polycyclic compounds 3c - e (Scheme 2). 
 
A third subset of compounds was designed taking into account 
that the dihydrophenanthrene 1 could also be a component of a 
variant of the U-4CR, known as the N-split-Ugi reaction, where 
the primary amine is replaced by a secondary diamine. [30] In this 
case, the use of piperazine as the amine component along with 
different isocyanides (Table 2) led to the corresponding adducts 
of general structure 4 (Scheme 3), with an alternative backbone 
that introduces a protonable tertiary amine and four sp3 carbons, 
enriching the complexity of the final compound in a single step. 
 
 
Scheme 2. Acidic cyclisation of the U-4CR products 2h-l to give the 
polycyclic compounds 3a-e.  
Reagents and conditions: a. HCOOH; -10°C; 1h 
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Scheme 3. N-split Ugi reaction between the 9,10-dihydrophenanthrene 1 
and piperazine to give compounds 4a-f.  
Reagents and conditions: a. R-NC / HCHO / methanol or ethanol; r.t; 
48h 
The library designed was synthesised via MCRs and post-
condensation reactions. 
The detailed experimental procedures for the synthesis of 
the library is described in the Supporting Information file. The 
new twenty-six compounds were obtained from 1 with yields 
ranging from 38 to 78% after purification, and their structures 
were corroborated by 1D and 2D NMR. In most cases, the 
NMR spectra showed the compounds as a mixture of 
conformers which are expected to originate from 
cis/transrotation around the N-substituted amide bonds.[31] 
As the interchange between the isomers is generally slower 
than the NMR time scale, the spectrum is the composite of 
the NMR spectra of the corresponding conformational 
isomers. For simplicity purposes, only the chemical shifts 
and coupling constants for the most populated conformer 
were described. Moreover, a direct analysis via high 
resolution electrospray ionisation mass spectrometry was 
performed in order to obtain an unambiguous 
characterisation of the compounds. 
 
Table 2. Isocyanides used in the N-split Ugi reaction of Scheme 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The phenanthrenoids designed are more complex than 
natural ones and interrogate a different region of the 
chemical space. 
Once the library was designed a question arose: how does the 
complexity of its members compare to that of natural 
phenanthrenoids? The resulting mean value of the Fsp3 metrics 
for the designed compounds was 0.40 (median = 0.39), which is 
significantly higher (99% confidence level in a Mann-Whitney test) 
than that found for the natural phenanthrenoids taken as 
reference (Figure 2a) and proves that this simple synthetic 
strategy is a powerful complexity-enhancing tool.  
 
Figure 2. a) Comparison of the frequency distribution of the Fsp3 score 
for the synthetic library and a set of natural phenanthrenoids. b) PMI plot 
showing the three-dimensional shape of the lowest-energy conformer of 
each compound in both sets. Calculations are described in the text. 
 
 
Compound R-NC 
4a  
4b 
 
4c 
 
4d 
 
4e 
 
4f 
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As the Fsp3 score is a topological metric based on the 2D structure 
of a molecule, a principal moment of inertia (PMI) analysis[32] was 
also performed in order to compare the three-dimensional shapes 
of the lowest-energy conformations of our synthetic library 
members with the phenanthrenoid reference set. Figure 2b shows 
that the synthetic compounds span across a wider region of the 
shape space, and that several of them lie near the rod-like vertex, 
a molecular shape that is usually found in bologically relevant 
compounds.[33,34] 
However, as previously discussed, there are several other factors 
that might contribute to the overall biological relevance of a library. 
To gain further insight into the similarities and differences 
between the sets of synthetic and natural phenanthrenoids, we 
performed an additional chemoinformatic analysis to calculate 16 
suitable molecular descriptors which are meant to grasp the 
topological, structural and physicochemical properties of a set of 
compounds.  These descriptors, previously validated by several 
researchers, [35,36] were taken as a base for a principal component 
analysis (PCA): the 16-dimension chemical space defined by 
these descriptors was projected onto 15 orthogonal axes 
(principal components), of which the first three (F1, F2 and F3) 
allow to represent 72% of the initial variability of the data. The plot 
depicted in Figure 3 shows that the two sets of compounds span 
across rather disjoint clustered regions of the reduced chemical 
space defined by these principal components. Moreover, the 
larger contributions to these axes can be seen to come from 
several original variables related to molecular complexity, not only 
the Fsp3 index, but also the number of heteroatoms, number of 
rings and rotable bonds. These analyses, when taken together, 
suggest not only that the designed library is enriched from the 
shape complexity point of view when compared to natural 
phenanthrenoids, but also that it comprises additional features 
that are often regarded to be crucial for a chemical entity to have 
a higher probability of exerting biological activity. 
 
Figure 3. Three-dimension biplot showing the different regions that the 
synthetic and natural phenanthrenoids occupy in a chemical space 
defined by the principal components F1, F2 and F3. The contribution of 
the most relevant descriptors (listed in the SI file) to these components is 
also depicted. 
Four hits with antiproliferative activity were identified in an 
in vitro screening. 
At this point the remaining question was whether the 
complexity-generating features introduced on the 
dihydrophenanthrene core did give the resulting chemotypes 
a higher chance of having biological relevance. Thus, we 
evaluated them in a cell-based biological assay, as this 
approach does not require prior knowledge of a particular 
molecular mechanism of action. [37,38] Taking into account the 
interesting antiproliferative and cytotoxic effects exerted by 
several natural phenantrenoids, our choice was a cell 
viability screening on human tumour cell lines. Needless to 
say, finding new compounds able to inhibit cell proliferation 
is a pressing need, not only for their potential clinical use but 
also because, in some instances, the effects seen for small 
molecules in cell-based screenings have revealed novel 
biological mechanisms underlying tumour progression.[39–41] 
 
A preliminary screening was initially performed in the human 
colorectal adenocarcinoma HT-29 cell line using the well-
established MTT assay [42] after cell treatment with each 
compound during 48 h. Most of the synthetic 
phenanthrenoids did not exert any effect below a 100 M 
concentration, but compounds 2e, 2f, 2g and 4f elicited a 
significant inhibition of cell viability, with IC50 values (the 
concentration needed to inhibit 50% of cell viability compared 
to that of the control) of 17, 63, 31 and 36 M, respectively. 
Compound 2e proved even more potent than 5-fluorouracil 
(5-FU), which showed an IC50 of 32 M in this experiment. 
Noteworthily, these compounds, depicted in Figure 4, share 
similar structural features and occupy a rather defined 
portion of the chemical space, suggesting the presence of a 
defined pharmacophore linked to a particular 
macromolecular target, which might pave the way for a 
further structure-activity relationship study based on the 
exploration of this particular region of the space. 
 
 
Figure 4. Three-dimension biplot showing that the phenanthrenoid mimics 
that exerted antiproliferative activity in vitro on HT-29 cells share similar 
coordinates in the chemical space (labelled red dots). 
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Figure 5. a) Dose-dependent effect of compound 2e on HT29, MDA-MB-231, A-549, PC3 and HEK293 cell viability by MTT assay. Data are expressed 
as relative viability (percentage of untreated control cells) and the IC50 values were obtained from three independent experiments. b) HT29, MDA-MB-
231, A-549, PC3 and HEK293 cells untreated or treated with compound 2e or 5-FU examined under a light microscope in randomly selected fields. 
 
Taking these results into account, 2e was selected as the most 
active compound to further study the selectivity of its effect on 
additional cell lines. Thus, similar viability assays were performed 
on malignant breast ductal carcinoma MDA-MB-231 cells, lung 
adenocarcinoma A-549 cells and prostate cancer PC3 cells, 
along with non-cancerous human embryonic kidney HEK293 cells. 
As shown in Figure 5, compound 2e proved to decrease the 
viability of all these cell lines with IC50s ranging from 15 to 35 M. 
Additional microscopy observations revealed significant changes 
in cell morphology. 
These results, obtained using the short-term MTT assay, were 
complemented with a longer in vitro cell survival assay  ‒the 
colony formation assay‒, which might be regarded as an indirect 
estimation of the antineoplastic effect of a compound.[43] 
Therefore, the ability of HT29 cells to grow and form foci was 
measured in the presence of 2e. Figure 6 shows that these cells, 
when treated with 2e, formed fewer and smaller colonies in a 
concentration-dependent manner compared to the control, which 
further proves 2e antiproliferative properties. 
 
Compound 2e exerts its antiproliferative activity via an 
apoptotic mechanism 
As apoptosis can be regarded as one of the most relevant 
molecular mechanisms in drug-induced cell death, and since 
some natural phenanthrenoids such as denbinobin were shown 
to induce cell death by this mechanism in different cell 
lines,[23,44,45] we decided to determine whether apoptosis could be 
involved in growth inhibition triggered by 2e. Thus, we performed 
a morphological analysis of cell death using fluorescence 
microscopy after staining nuclear DNA of HT29 cells with 4′,6-
diamidino phenylindole (DAPI), [46] and found that treated cells 
showed the typical morphological characteristics of apoptotic 
cells: nuclear condensation and fragmentation, cell shrinkage and 
fragmentation into apoptotic bodies. 
 
 
 
Figure 6. a) Clonogenic assay of HT29 cells untreated or treated with 
compound 2e or 5-FU for 24 h. Photographs of petri-dishes in 
representative experiments. b) Percentage of colonies formed with 
respect to untreated control (relative number of colonies) 
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Figure 7. a) Representative fluorescence microscopy images after 
staining nuclear DNA with DAPI. b) Cell death induced by compound 2e 
in the presence absence of a pan-caspase inhibitor. Activity on cell 
viability determined by MTT assay. Results are expressed as the mean ± 
standard deviation of three independent experiments performed in 
duplicate, ** p < 0.01, **** p < 0.001.)  
However, the precise mechanism of denbinobin apoptosis 
induction has not been fully delineated, but the cytotoxic activity 
seems to involve activation of caspase-3.[44] Therefore, our 
cytological observations were complemented with pre-incubation 
of HT29 cells with 10 μM of Z-VAD-FMK for 4 h, a pan-caspase 
inhibitor that blocks apoptosis,[47] and co-incubation of the cells 
treated with 25 μM 2e for another 48 h. Figure 7 shows that cell 
death promoted by 2e was partially reversed when cells were 
treated with the pan-caspase inhibitor, which suggests that 
caspases are at least in part involved in the mechanism of the cell 
death induced by this compound. Therefore, the results showed 
herein strongly suggest that the mimics described in this work 
share some pharmacological features with the NPs that served as 
inspiration for their design.   
Conclusions 
With the advent of high-throughput screening techniques, much 
effort has been devoted to the design of the “ideal” library for 
screening, both in terms of size and synthetic efficiency.[48] In this 
vein, the BIOS approach is probably one of the most appealing 
methods, which, as stated above, builds on the fact that 
macromolecules and natural products have co-evolved to render 
highly diverse and complex structures by combining a limited set 
of fragments.  
On the other hand, it is becoming clearer nowadays that, for a 
library to contain biologically relevant chemical entities, it should 
incorporate some degree of structural complexity, a concept 
which, even if quite intuitive, has no sharp quantitative definition. 
Although the simple guidelines for introducing complexity 
proposed by Feher and Schmidt in their seminal work have been 
discussed by several researchers, they have been usually applied 
ex post facto in order to rationalise the discovery of new bioactive 
molecules among members of chemistry-driven designed 
libraries. In fewer cases, these guidelines served for designing 
new interesting chemotypes, but almost no further studies on their 
biological properties have been reported.[15,19,49] 
The present work might then be considered a proof of concept 
showing that the BIOS approach can be complemented with a 
simple complexity-enhancing synthetic methodology in order to 
obtain smaller, but still biologically relevant libraries with active 
members when assayed in a phenotypic screening. In this sense, 
Nilar et al. have proposed that compounds having an increased 
degree of complexity improve the likelihood of activity in 
phenotypic screenings,[50] as these assays simultaneously 
measure interactions with multiple macromolecular targets, each 
one having in turn various degrees of complexity. 
In this case, four antiproliferative compounds have emerged from 
a set of only twenty-six members, an outstanding hit rate. 
Moreover, one of them showed a more potent in vitro activity 
when compared to that of a clinically useful antitumour drug. It is 
important to point out that it this work constitutes the first report 
on the synthesis of mimics of this family of natural products, and 
that the simplicity of the synthetic approach might also pave the 
way for an efficient hit-to-lead optimisation. In addition, such 
simplicity offers a tool to face the important problem posed by the 
low abundance of NPs when searching for novel bioactive 
compounds. For example denbinobin, the most studied natural 
phenanthrenoid, can be isolated from its natural source with a 
0.002% yield, which has hampered its more detailed 
pharmacological investigation until the development of total 
synthesis that, in turn, comprises several steps and the need of 
sophisticated synthetic procedures.[51] 
 
Taken as a whole, our results suggest that the rather simple 
approach presented herein, which we have dubbed as a 
minimalist design approach, might be envisaged as an efficient 
way to address the challenging first steps of the drug discovery 
process. 
Finally, as many of the natural phenanthrenoids that have inspired 
our synthetic library show biological activities other than 
antiproliferative, thus, it would be interesting to perform 
phenotypic screenings on alternative biological systems. Further 
studies are underway to address this issue. 
Experimental Section 
Synthesis of the library 
For a full experimental description of the synthesis and characterisation of 
the new compounds, please see the SI file. The structures were confirmed 
by 1D and 2D NMR spectroscopy from spectra recorded on a Bruker AM-
500 (500 MHz for 1H and 125 MHz for 13C). Chemical shifts (δ) are given 
in ppm downfield from TMS as the internal standard. Coupling constant (J) 
values are in Hz. HRMS (ESI) analysis were performed on a Bruker 
micrOTOF-Q II. Furthermore, combustion analyses for the new 
compounds were performed on an Exeter CE 440 Elemental Analyzer and 
were within ± 0.4 % of the theoretical values. Melting points were 
determined on a Fisher Johns apparatus and are uncorrected.  
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Compound 1 was obtained by adapting the procedure described by Boots 
and Johnson.[27] The synthesis of two representative members of the 
library are described below: 
Compound 2e: The acid 1 (50 mg, 0.16 mmol) was added to a solution of 
(4-methoxybenzyl)amine (22 µL, 0.16 mmol) and 15 µL of 37% aq 
formaldehyde (0.18 mmol) in 3 mL of ethanol. The mixture was stirred for 
15 min at room temperature and then 0.18 mmol (35 L) of diethyl 
(isocyanomethyl)phosphonate were added. The reaction was kept under 
the same conditions until total disappearance of the acid (usually 48 h). 
The solvent was evaporated under reduced pressure and the residue was 
taken in dichloromethane and washed with NaOH (5% aq.). The combined 
organic layers were dried over anhydrous sodium sulfate and evaporated. 
The crude products were purified by silica gel column chromatography 
(hexane/EtOAc gradient) to give compound 2e as a white powder (65 mg, 
65% yield); m.p.: 103°C; 1H NMR (500 MHz, CDCl3) δ = 1.26 (t, J = 7.1 , 
3H), 1.34 (t, J = 7.0 , 3H), 2.30 (s, 3H), 2.58 (m, 2H), 2.73 (m, 2H), 2.75 
(m, 2H), 3.08 (m, 2H), 3.71 (dd, J = 12.1 and 5.9, 2H), 3.78 (s, 3H), 3.83 (s, 
3H), 4.03 (s, 2H), 4.12 (q, J = 7.0, 2H), 4.15 (q, J = 7.1, 2H), 4.55 (s, 2H), 
6.74 (NH, t, J = 5.9, 1H), 6.76 (d, J = 2.7, 1H), 6.82 (dd, J = 8.8 and 2.8 , 
1H), 6.85 (d, J = 8.8, 2H), 7.03 (d, J = 8.2, 2H), 7.07 (d, J = 8.0, 1H), 7.47 
(d, J = 7.9, 1H), 7.60 (d, J = 8.6, 1H); 13C NMR (125 MHz, CDCl3) δ = 16.6, 
16.63, 20.2, 25.0, 25.2, 29.6, 32.7, 34.3 (d, JC-P = 157), 50.1, 51.9, 55.4, 
55.5, 62.7 62.8, 112.5, 113.1, 114.6, 121.7, 125.1, 127.5, 127.8, 127.9, 
128.9, 133.0, 134.9, 134.9, 136.4, 138.5, 158.9, 159.5, 169.0, 173.9; 
HRMS (ESI) m/z calcd for (M+Na+) C34H43N2O7PNa: 645.2700, found: 
645.2689.  
Compound 4f: The same procedure described before was followed, but 
using 14 mg (0.16 mmol) of piperazine as the amine component and 1-(2-
isocyanoethyl)-4-methoxybenzene (29 mg, 0.18 mmol) as the isocyanide 
component. After purification, 47 mg of compound 2f (53% yield) as a pale 
yellow powder was obtained; m.p.: 181°C; 1H NMR (500 MHz, CDCl3) δ = 
2.22 (t, J = 5.0, 2H), 2.34 (t, J = 5.0, 2H), 2.36 (s, 3H), 2.44 (m, 2H), 2.78 
(t, J = 6.8, 2H), 2.81 (m, 2H), 2.84 (m, 2H), 2.92 (s, 2H), 3.07 (m, 2H), 3.19 
(t, J = 4.9, 2H), 3.51 (t, J = 5.0, 2H), 3.54 (m, 2H), 3.76 (s, 3H), 3.84 (s, 
3H), 6.78 (d, J = 2.7, 1H), 6.83 (d, J = 8.6, 2H), 6.84 (dd, J = 8.6 and 2.7, 
1H), 7.00 (t, J = 5. , 1H), 7.09 (d, J = 8.6, 2H), 7.10 (d, J = 7.9, 1H), 7.49 
(d, J = 7.9, 1H), 7.62 (d, J = 8.6, 1H); 13C NMR (125 MHz, CDCl3) δ = 20.3, 
25.1, 25.2, 29.6, 32.6, 34.7, 39.9, 41.7, 45.5, 53.2, 53.6, 55.4, 61.5, 112.5, 
113.1, 114.2, 121.7, 125.2, 128.0, 128.9, 129.7, 130.8, 133.1, 134.9, 135.0, 
136.6, 138.5, 158.5, 159.0, 169.5, 170.9; HRMS (ESI) m/z calcd for 
(M+Na+) C34H41N3NaO4: 578.2989, found: 578.2991.  
Chemoinformatic analysis 
The structures of the natural phenanthrenoids were obtained from the 
literature and are listed in the SI file. JChem for Excel was used for 
calculations of the Fsp3 metrics, other structure-based properties and 
generation of the lower -energy conformations of the compounds (release 
16.10.1700.1231, 2016, ChemAxon; http://www.chemaxon.com). 
Conformations were re-optimized to the AM1 semiempirical level and the 
principal moments of inertia for the resulting structures were calculated 
using Hyperchem (release 7.5 for Windows, HyperCube Inc; 
http://www.hyper.com). Principal component and additional statistical 
analysis were performed using OriginPro 2017 (release b9.4.0.220; 
http://www.OriginLab.com).  
Biological assays 
Cell viability in all experiments was determined by the colourimetric MTT 
assay. Detailed experimental procedures can be found in the SI file. The 
statistical analysis of the experiments was performed using GraphPad 
Prism version 6.01 for Windows (GraphPad Software, La Jolla, CA, USA; 
www.graphpad.com). 
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We describe the design of a small library of natural product mimics where structural complexity was introduced following simple 
guidelines, while maintaining a low synthetic cost, by using multicomponent reactions. The resulting compounds, inspired on the 
phenanthrenoid scaffold, yielded a new antiproliferative chemical entity which resulted more potent than 5-fluorouracil in cell-based 
assays. 
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